Fibromuscular dysplasia (FMD) and segmental arterial mediolysis (SAM) are noninflammatory, nonatherosclerotic arterial diseases that cause aneurysm, occlusion, and thromboses. These diseases are rarely seen in mesenteric arterial lesions; however, as they can be lethal if appropriate management is not provided, the accumulation of clinical information from cases is essential. We herein report the cases of a 57-year-old man diagnosed with FMD and a 63-year-old man diagnosed with SAM. We conclude that an early diagnosis with imaging modalities and clinical information followed by the appropriate treatment improves the prognosis of these arterial diseases.
Introduction
Mesenteric vascular diseases include ischemic changes due to atherosclerotic changes and noninflammatory, nonatherosclerotic arterial diseases of fibromuscular dysplasia (FMD) and segmental arterial mediolysis (SAM). Although atherosclerotic diseases are rather common, and FMD and SAM were originally diagnosed by histological analyses after surgery or upon an autopsy, recent advances in imaging modalities have led to increasing frequencies of FMD and SAM diagnoses. As these diseases can affect various organs and be lethal if not properly managed, an appropriate diagnosis followed by treatment in the early phase is essential (1, 2) . However, as the disease entities are rare, we have summarized the characteristics of FMD and SAM in the gastroenterologic regions and reviewed reported cases with a comparison of the imaging findings and histological analyses (3) .
To understand these diseases in mesenteric arteries further and diagnose them based on available clinical information and imaging findings, we herein report two recently experienced cases of FMD and SAM with updated information from recently published cases focusing on the mesenteric re-gions.
Case Reports

Case 1
A 57-year-old man was admitted to our hospital with a chief complaint of acute-onset severe and continuous sharp epigastric pain with no trigger. The pain gradually reduced, but the abdominal discomfort persisted.
He had a history of untreated hypertension, hyperlipidemia, and diabetes. He had been a smoker for 33 years (1 pack/day). Upon admission to our hospital, he had a blood pressure of 142/98 mmHg, heart rate of 92 beats/min, and temperature of 36.5 . Laboratory findings showed a mild elevation of the white blood cell count (12,800/μL) and Creactive protein (7.49 mg/dL), blood sugar (152 mg/dL), lactate dehydrogenase (LDH; 243 IU/L), creatinine kinase (538 IU/L), and hemoglobin A1c (6.5%). Computed tomography (CT) and three-dimensional reconstruction showed arterial stenosis, aneurysmal changes, and partial dissection in the superior mesenteric artery (Fig. 1a -c) as well as stenosis and aneurysmal changes in the branch of the right renal artery ( Fig. 1d, e ). Magnetic resonance angiography (MRA) Intern Med 58: 3393-3400, 2019 DOI: 10.2169/internalmedicine.3094-19 showed stenosis (red arrows) and aneurysmal changes (red arrowheads) in the left vertebral artery ( Fig. 1f ). Because of his noninflammatory, nonatherosclerotic multiple arterial lesions in the midsized arteries, hypertension, and long history of smoking, we diagnosed him with FMD.
Given the diagnosis of FMD and persistently high blood pressure at 160/90 mmHg, antihypertensive therapy was started with continuous intravenous infusion of nicardipine (2 μg/kg/min) followed by the oral administration of valsartan (40 mg/day) starting on hospital day 7, which successfully brought down the blood pressure to 110/60 mmHg. In addition, to prevent cerebral infarction because of aneurysmal lesions in the left vertebral artery, anticoagulant therapy was also started with continuous intravenous infusion of heparin (10,000 IU/day) on hospital day 11, followed by the oral administration of aspirin (81 mg/day). As the epigastric symptoms disappeared soon after the blood pressure came under control, they were considered to have been due to the progression of stenotic changes with vasoconstriction of mesenteric arterial lesions due to the increase in the blood pressure. With treatment of valsartan (40 mg/day) and aspirin (81 mg/day) for 18 months, no recurrence of the symp-toms or other complications have been noted to date.
Case 2
A 63-year-old man was admitted to our hospital with a chief complaint of left-sided abdominal pain that showed slow progression from the day before the admission. He was a nonsmoker and had no history of illness.
Upon admission to our hospital, he had a blood pressure of 129/84 mmHg, heart rate of 75 beats/min, and temperature of 36.9 . Other than the mild elevation of his white blood cell count (12,090/μL) and LDH (283 IU/L), no abnormal findings were noted. CT and three-dimensional reconstruction showed bleeding in the abdominal cavity and dissecting aneurysm in the celiac artery to the splenic artery ( Fig. 2a-c ). In addition, the bilateral external iliac arteries showed multiple aneurysmal changes and partial dissection ( Fig. 2d-f ). Because of noninflammatory, nonatherosclerotic multiple arterial diseases, dissecting aneurysm of the celiac and splenic arteries, and bleeding in the abdominal cavity probably from the arterial lesions, we diagnosed him with SAM.
As the symptoms significantly improved after admission with no increase in the bleeding in the abdominal cavity on day 2 or recurrence of the symptoms, and the hematoma decreased significantly on day 7, no emergent intervention or additional medication was started. However, in order to monitor the size of the aneurysmal changes and dissection, scheduled CT was performed every three to six months, and the blood pressure was carefully monitored. No recurrence of the symptoms or other complications has been noted in 16 months of follow-up.
Discussion
FMD and SAM are noninflammatory, nonatherosclerotic arterial diseases originally diagnosed based on histological findings; however, with marked advances in imaging modalities, including CT and magnetic resonance imaging, opportunities to diagnose these diseases based on imaging findings and clinical information without a pathological examination are increasing (3).
The clinical and pathological classification of FMD was first reported by Harrison and McCormack in 1971 (4) , and recently, data belonging to the first 447 patients from the U.S. Registry for FMD were reported (5) . FMD is a rare, medium-sized arterial disease occurring throughout the body with a frequency of 0.02%, predominantly in women (5) . In addition, smoking, hormones, HLA-DRw6 polymorphism, and physiologic stimulation have been reported to be risk factors (6) . The histologic changes in the arterial muscle replaced by fibroplasia can lead to arterial stenosis, occlusion, aneurysm, and dissection, and such events typically occur in the renal, extracranial, carotid, and vertebral arteries. Therefore, although rare, mesenteric FMD can cause unspecific abdominal pain, diarrhea, nausea, and vomiting (2) . Imaging studies, including CT and angiography, reveal the narrowing and aneurysmal changes of the vasculature that lead to a beaded appearance (1). Our Case 1 also had a history of smoking, and CT showed a multiple-beaded aneurysmal appearance and partial dissection of the superior mesenteric and right renal arteries. In addition, MRA showed stenosis and dissection of the left vertebral artery, which is rather typical for FMD. Therapeutic options include antiplatelet, antithrombotic, and antihypertensive therapy (7) , and our Case 1 was also successfully treated with these approaches with no recurrence.
SAM was first reported by Slavin and Gonzalez-Vitale in 1976 (8) and is a rare disease, with 50 cases reported to date. SAM is caused by the disruption of the arterial medial layer of a medium-to large-sized artery, and its risk factors include hypoxia, shock, hypertension, circulatory disturbance, and other vasoconstrictor stimuli (2, 8, 9) . Because of Table 1 . Summary of FMD Casesreported Recently. the involvement of larger arteries than FMD, the rupture of an aneurysm in these arteries can be life-threatening. Histologically, vacuolization and lysis of the outer arterial media can be seen (8) , which can lead to aneurysm, dissection, occlusion, and stenosis. Mesenteric SAM in the splenic, celiac, hepatic, and mesenteric arteries can cause abdominal symptoms, including nonspecific abdominal and flank pain, diarrhea, nausea, and back pain caused by aneurysm and dissection (2, 9, 10) . CT and MRA have shown aneurysms, dissection, occlusion, and stenosis. Therapeutic options include antihypertensive therapy (11) , embolization, bypass, and resection of the injured arteries. Patients presenting acutely with intraabdominal hemorrhaging are treated with emergent catheter angiography, endovascular intervention, or surgical treatment (12) . Our Case 2 also suffered from abdominal pain, which had been caused by the minor rupture of a small aneurysm in the branch of the celiac or splenic artery; however, as the symptoms improved smoothly and the aneurysm was located on the main trunk of the celiac artery, no emergent intervention was performed. Fortunately, no recurrence has been seen to date; however, a careful follow-up of the aneurysm by imaging has been performed once every three to six months. In addition to our Case 2, Cases 12 and 13 improved with conservative therapy, although hemoperitoneum was found in abdominal cavity ( Table 2 ). These three cases showed no progression of hemoperitoneum and no extravasation upon admission, so these signs may be markers supporting the selection of conservative treatment. Due to difficulty in collecting tissue samples from the arteries in these areas, the importance of imaging studies is increasing, and although some similarities in the radiologic and histologic diagnoses have been reported for FMD and SAM, the two diseases show different clinical profiles in terms of the age of onset, gender, distribution of the affected arteries, imaging, symptoms, and treatment. It is therefore possible to diagnose these diseases clinically and suggest appropriate therapeutic options ( Table 1 , 2). For example, FMD affects middle-aged women, whereas there is no predilection for age or gender for SAM (3, 5, 13, 14) . In addition, while FMD often shows stenosis and aneurysms in medium-sized arteries, including the renal, extracranial, carotid, and vertebral arteries (12) , SAM shows changes in larger arteries, such as the celiac and mesenteric arteries (13), leading to a higher risk of arterial rupture and hemorrhaging from the weakened arterial wall in these larger arteries (15) .
To improve our understanding of these diseases, we recently reviewed the reported cases of FMD and SAM in the gastroenterologic regions (3, 9, 11, (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) and reported the characteristics of imaging studies. For a further understanding of the clinical characteristics, we updated the information, focusing on cases reported within the past 20 years, since imaging modalities have shown significant advances in this time period . Based on the obtained information, CT revealed stenosis and aneurysmal changes in 33 cases (77%) of FMD and aneurysm, dissection, occlusion, and stenosis in 28 cases (88%) of SAM. In addition, hemorrhaging or hematoma was seen in 15 cases (47%) of SAM. Our cases also showed a similar pattern to the previously reported cases. Regarding the therapeutic options, open surgery was performed in 56%, endovascular intervention in 23%, antihypertensive therapy in 19%, and anticoagulation therapy in 11.6% for FMD. In contrast, open surgery was performed in 41%, endovascular intervention in 42%, antihypertensive therapy in 6.3%, and anticoagulation therapy in 6.3% for SAM (including Case 2). These data clearly demonstrate that early imaging studies and appropriate decisionmaking are essential for successful management.
Interestingly, 13 cases of FMD (30%) and 19 cases of SAM (59%), mainly recent cases, have been diagnosed without histological examinations and administered appropriate therapies, indicating that the accumulation of the information and results of imaging studies encouraged physicians to be suspicious of and diagnose the cases.
In conclusion, FMD and SAM are rare, and no standard diagnostic criteria or therapeutic methodologies have yet been established. The accumulation of similar cases and the summary of the clinical characteristics of the reported cases are important. In this report, we described two representative recent cases and summarized the findings of cases reported recently in order to improve the understanding and knowledge of these diseases. Further cases and the accumulation of clinical information will help physicians diagnose and treat such cases and facilitate the development of diagnostic criteria and standard therapeutic options.
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